SEC Tracker
Get the app
PFHO · XBRL financial data

Pacific Health Care Organization financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (PFHO's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue1,642*1,3981,5701,5281,541*1,8191,7271,5871,583*1,4981,7751,513
General and administrative163*136213193192*153228186187*181187207
Total operating expenses1,338*1,2231,3781,3761,207*1,5041,4231,3821,405*1,3251,4051,378
Operating income (loss)304*175192152334*314304205178*173369134
Interest income104*———————————
Interest expenseyear only0004*2000*000
Income tax expense (benefit)131*778390129*1142598747*74137137
Net income (loss)281*197216175296*293637223235*194327335
Earnings per share, basic USD per share0.02*0.020.020.010.02*0.020.050.020.02*0.020.030.03
Earnings per share, diluted USD per share0.02*0.020.020.010.02*0.020.050.020.02*0.020.030.03
Weighted average shares, basic thousands of shares12,800*12,80012,80012,80012,800*12,80012,80012,80012,800*12,80012,80012,800
Weighted average shares, diluted thousands of shares12,816*12,81612,81612,81612,816*12,81612,81612,81612,816*12,81612,81612,816

Balance sheet

CSV

Fiscal quarters (PFHO's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents2,5662,8392,6192,5462,0702,3572,1562,1792,1692,3972,2402,653
Accounts receivable1,0538799411,0931,0299331,0921,0181,0061,0661,3301,094
Total current assets11,68311,91411,87112,07412,33512,55813,21913,22513,38813,69314,04014,304
Property and equipment, net777265585254484352464541
Right-of-use asset5647000———————
Total assets11,82412,04011,94312,13912,43312,65713,31513,29313,46313,76514,11214,368
Accounts payable160148163175148219148194228214232172
Accrued liabilities368336424440423273340186127179230191
Total current liabilities1,0081,027726748746677698453389497516437
Lease liability, non-current1212000———————
Total liabilities1,0201,039726748746———————
Retained earnings10,37510,57210,78810,96311,25811,55112,18812,41112,64612,84013,16713,501
Total stockholders' equity10,80411,00111,21711,39111,68711,98012,61712,84013,07513,26913,59613,930
Total liabilities and equity11,82412,04011,94312,13912,43312,65713,31513,29313,46313,76514,11214,368
Common shares outstanding (cover page) thousands of shares12,80012,80012,80012,80012,80012,80012,80012,80012,80012,80012,80012,800

Cash flows

CSV

Fiscal quarters (PFHO's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)281*197216175296*293637223235*194327335
Depreciation and amortization10*9987*76*5*6*55*5*
Net cash from operating activities501*291(41)*(72)*497*331455*24*351*228(5)*507*
Purchases of property and equipment13*42*2*2*90*1*14*05*1*
Net cash from investing activities(295)*(4)(178)*(2)*(950)*(9)(656)*(1)*(325)*0(152)*(94)*
Dividends paid0*140*0*(14)*——0*36*——0*
Net cash from financing activities(0)*(14)0*0*49*(35)(1)*(0)*(36)*00*0*

Compare with peers

SIC 8090 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8090 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Pacific Health Care Organization2,6531,513507*12.8M— 10-QSep 30, 2026
BioCorRx2188(440)*29.8M0.0 quarters 10-QJun 30, 2026
AnTix Holdings14not reportednot reported70.7M— 10-KJun 30, 2025
Marpai1384,166(4,099)*26.8M0.0 quarters 10-QJun 30, 2026
BioRestorative Therapies3,11323(3,808)25.5M0.9 quarters 10-QMar 31, 2026
Mangoceuticals22969(261)*21.6M0.9 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.